Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone

Overview of attention for article published in Experimental Hematology & Oncology, September 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION OF ATR KINASE INHIBITORS WITH RADIUM-223 SALT

Application WO-2018153969-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.